{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:01Z","timestamp":1792784041530,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Joint Special Project of Applied Basic Research of Yunnan University of Traditional Chinese Medicine","award":["202101AZ070001-128"],"award-info":[{"award-number":["202101AZ070001-128"]}],"id":[{"id":"https:\/\/ror.org\/04zap7912","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11626-026-01177-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:14:47Z","timestamp":1774984487000},"page":"754-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ginsenoside F1 ameliorates nonalcoholic fatty liver disease by activating the AMPK\/PGC-1\u03b1 pathway and autophagy"],"prefix":"10.1007","volume":"62","author":[{"given":"Wenjiao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","volume":"77","author":"GA Baselli","year":"2022","unstructured":"Baselli GA, Jamialahmadi O, Pelusi S, Ciociola E, Malvestiti F, Saracino M, Santoro L, Cherubini A, Dongiovanni P, Maggioni M, Bianco C, Tavaglione F, Cespiati A, Mancina RM, D\u2019Ambrosio R, Vaira V, Petta S, Miele L, Vespasiani-Gentilucci U, Federico A, Pihlajamaki J, Bugianesi E, Fracanzani AL, Reeves HL, Soardo G, Prati D, Romeo S, Valenti LV (2022) Rare ATG7 genetic variants predispose patients to severe fatty liver disease. J Hepatol 77:596\u2013606","journal-title":"J Hepatol"},{"key":"1177_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109414","volume":"120","author":"P Cao","year":"2023","unstructured":"Cao P, Wang Y, Zhang C, Sullivan MA, Chen W, Jing X, Yu H, Li F, Wang Q, Zhou Z, Wang Q, Tian W, Qiu Z, Luo L (2023) Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. J Nutr Biochem 120:109414","journal-title":"J Nutr Biochem"},{"issue":"23","key":"1177_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu17233693","volume":"17","author":"BY Chang","year":"2025","unstructured":"Chang BY, Kim I, Park H, Kim S, Kim SY (2025) Protective role of ginsenoside F1-enriched extract (SGB121) in metabolic dysfunction-associated fatty liver disease (MAFLD). Nutrients 17(23):3693. https:\/\/doi.org\/10.3390\/nu17233693","journal-title":"Nutrients"},{"key":"1177_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710055","author":"CL Chen","year":"2022","unstructured":"Chen CL, Lin YC (2022) Autophagy dysregulation in metabolic associated fatty liver disease: a new therapeutic target. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231710055","journal-title":"Int J Mol Sci"},{"key":"1177_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103230","volume":"74","author":"D Cheng","year":"2024","unstructured":"Cheng D, Zhang M, Zheng Y, Wang M, Gao Y, Wang X, Liu X, Lv W, Zeng X, Belosludtsev KN, Su J, Zhao L, Liu J (2024) \u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1\u03b1\/Nrf2 pathway. Redox Biol 74:103230","journal-title":"Redox Biol"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s10620-015-4025-x","volume":"61","author":"MJ Czaja","year":"2016","unstructured":"Czaja MJ (2016) Function of autophagy in nonalcoholic fatty liver disease. Dig Dis Sci 61:1304\u20131313","journal-title":"Dig Dis Sci"},{"key":"1177_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116927","volume":"318","author":"P Gong","year":"2024","unstructured":"Gong P, Long H, Guo Y, Wang Z, Yao W, Wang J, Yang W, Li N, Xie J, Chen F (2024) Chinese herbal medicines: the modulator of nonalcoholic fatty liver disease targeting oxidative stress. J Ethnopharmacol 318:116927","journal-title":"J Ethnopharmacol"},{"key":"1177_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415489","author":"X Guo","year":"2022","unstructured":"Guo X, Yin X, Liu Z, Wang J (2022) Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232415489","journal-title":"Int J Mol Sci"},{"issue":"18","key":"1177_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814241","volume":"24","author":"J Hou","year":"2023","unstructured":"Hou J, Yun Y, Jeon B, Baek J, Kim S (2023) Ginsenoside F1-mediated telomere preservation delays cellular senescence. Int J Mol Sci 24(18):14241. https:\/\/doi.org\/10.3390\/ijms241814241","journal-title":"Int J Mol Sci"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2022.04.010","volume":"77","author":"X Jiang","year":"2022","unstructured":"Jiang X, Fulte S, Deng F, Chen S, Xie Y, Chao X, He XC, Zhang Y, Li T, Li F, McCoin C, Morris EM, Thyfault J, Liu W, Li L, Davidson NO, Ding WX, Ni HM (2022) Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis. J Hepatol 77:619\u2013631","journal-title":"J Hepatol"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1134\/S0006297921110055","volume":"86","author":"W Lin","year":"2021","unstructured":"Lin W, Jin Y, Hu X, Huang E, Zhu Q (2021) AMPK\/PGC-1\u03b1\/GLUT4-mediated effect of icariin on hyperlipidemia-induced non-alcoholic fatty liver disease and lipid metabolism disorder in mice. Biochemistry (Mosc) 86:1407\u20131417","journal-title":"Biochemistry (Mosc)"},{"key":"1177_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117601","volume":"252","author":"W Lu","year":"2020","unstructured":"Lu W, Mei J, Yang J, Wu Z, Liu J, Miao P, Chen Y, Wen Z, Zhao Z, Kong H, Wu C, Yang Y, Chen M (2020a) ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK\/mTOR mediated autophagy. Life Sci 252:117601","journal-title":"Life Sci"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1152\/ajpendo.00181.2019","volume":"318","author":"Z Lu","year":"2020","unstructured":"Lu Z, Li Y, Syn WK, Wang Z, Lopes-Virella MF, Lyons TJ, Huang Y (2020b) Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. Am J Physiol Endocrinol Metab 318:E131\u2013E144","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/ptr.6865","volume":"35","author":"C Luo","year":"2021","unstructured":"Luo C, Sun H, Peng J, Gao C, Bao L, Ji R, Zhang C, Zhu W, Jin Y (2021) Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1\/TAZ-PPAR\u03b3\/PGC-1\u03b1 signaling pathway. Phytother Res 35:1010\u20131022","journal-title":"Phytother Res"},{"key":"1177_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020818","author":"N Nasiri-Ansari","year":"2021","unstructured":"Nasiri-Ansari N, Nikolopoulou C, Papoutsi K, Kyrou I, Mantzoros CS, Kyriakopoulos G, Chatzigeorgiou A, Kalotychou V, Randeva MS, Chatha K, Kontzoglou K, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E (2021) Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE((-\/-)) mice by activating autophagy and reducing ER stress and apoptosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020818","journal-title":"Int J Mol Sci"},{"key":"1177_CR16","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397:2212\u20132224","journal-title":"Lancet"},{"key":"1177_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","volume":"20","author":"Q Ren","year":"2024","unstructured":"Ren Q, Sun Q, Fu J (2024) Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. Autophagy 20:221\u2013241","journal-title":"Autophagy"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/hep.28524","volume":"64","author":"M Rinella","year":"2016","unstructured":"Rinella M, Charlton M (2016) The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health. Hepatology 64:19\u201322","journal-title":"Hepatology"},{"key":"1177_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2403653","volume":"46","author":"M Shao","year":"2024","unstructured":"Shao M, Chen J, Zhang F, Su Q, Lin X, Wang W, Chen C, Ren H, Zheng S, Hui S, Qin S, Ni Y, Zhong J, Yang J (2024) 4-octyl itaconate attenuates renal tubular injury in db\/db mice by activating Nrf2 and promoting PGC-1\u03b1-mediated mitochondrial biogenesis. Ren Fail 46:2403653","journal-title":"Ren Fail"},{"key":"1177_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154561","volume":"109","author":"B Shen","year":"2023","unstructured":"Shen B, Wang Y, Cheng J, Peng Y, Zhang Q, Li Z, Zhao L, Deng X, Feng H (2023) Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine 109:154561","journal-title":"Phytomedicine"},{"key":"1177_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1374644","volume":"15","author":"Q Shen","year":"2024","unstructured":"Shen Q, Yang M, Wang S, Chen X, Chen S, Zhang R, Xiong Z, Leng Y (2024) The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease. Front Endocrinol (Lausanne) 15:1374644","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1177_CR22","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10572","volume":"22","author":"W Shi","year":"2021","unstructured":"Shi W, An L, Zhang J, Li J (2021) Periplaneta americana extract ameliorates lipopolysaccharide-induced liver injury by improving mitochondrial dysfunction via the AMPK\/PGC-1\u03b1 signaling pathway. Exp Ther Med 22:1138","journal-title":"Exp Ther Med"},{"key":"1177_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010056","author":"N Vallianou","year":"2021","unstructured":"Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M (2021) Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives. Biomolecules. https:\/\/doi.org\/10.3390\/biom12010056","journal-title":"Biomolecules"},{"key":"1177_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-023-00730-6","volume":"25","author":"X Wang","year":"2024","unstructured":"Wang X, Wang J, Ying C, Xing Y, Su X, Men K (2024) Fenofibrate alleviates NAFLD by enhancing the PPAR\u03b1\/PGC-1\u03b1 signaling pathway coupling mitochondrial function. BMC Pharmacol Toxicol 25:7","journal-title":"BMC Pharmacol Toxicol"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/a-1293-8250","volume":"53","author":"F Wen","year":"2021","unstructured":"Wen F, Shi Z, Liu X, Tan Y, Wei L, Zhu X, Zhang H, Zhu X, Meng X, Ji W, Yang M, Lu Z (2021) Acute elevated resistin exacerbates mitochondrial damage and aggravates liver steatosis through AMPK\/PGC-1\u03b1 signaling pathway in male NAFLD mice. Horm Metab Res 53:132\u2013144","journal-title":"Horm Metab Res"},{"key":"1177_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","volume":"73","author":"X Wu","year":"2020","unstructured":"Wu X, Poulsen KL, Sanz-Garcia C, Huang E, McMullen MR, Roychowdhury S, Dasarathy S, Nagy LE (2020) MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol 73:616\u2013627","journal-title":"J Hepatol"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"YC Wu","year":"2024","unstructured":"Wu YC, Yan Q, Yue SQ, Pan LX, Yang DS, Tao LS, Wei ZY, Rong F, Qian C, Han MQ, Zuo FC, Yang JF, Xu JJ, Shi ZR, Du J, Chen ZL, Xu T (2024) NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci 20:2219\u20132235","journal-title":"Int J Biol Sci"},{"key":"1177_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155200","volume":"131","author":"LS Yan","year":"2022","unstructured":"Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, Pan SY, Zhang Y (2022) Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway. Metabolism 131:155200","journal-title":"Metabolism"},{"key":"1177_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05060-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qiu W, Xiao J, Sun J, Ren X, Jiang L (2024) Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway. J Transl Med 22:309","journal-title":"J Transl Med"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ptr.7662","volume":"37","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang Y, Wang Z, Lei L (2023a) Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR\/ULK1-dependent pathway in nonalcoholic fatty liver disease. Phytother Res 37:781\u2013797","journal-title":"Phytother Res"},{"key":"1177_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jgr.2022.06.002","volume":"47","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Ma J, Liu S, Chen C, Li Q, Qin M, Ren L (2023b) Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT\/Bcl-2 signaling pathways. J Ginseng Res 47:106\u2013116","journal-title":"J Ginseng Res"},{"key":"1177_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.826628","volume":"12","author":"F Zhou","year":"2021","unstructured":"Zhou F, Ding M, Gu Y, Fan G, Liu C, Li Y, Sun R, Wu J, Li J, Xue X, Li H, Li X (2021) Aurantio-obtusin attenuates non-alcoholic fatty liver disease through AMPK-mediated autophagy and fatty acid oxidation pathways. Front Pharmacol 12:826628","journal-title":"Front Pharmacol"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-026-01177-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:42:45Z","timestamp":1783179765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-026-01177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s11626-026-01177-9","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments involved in this study strictly follow the animal experiment management regulations of relevant institutions and countries. All experimental protocols have been approved by the Animal Ethics Committee of BeisiTai Biotechnology Co., LTD (Approval number: BST-RAT-20230602\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}